B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?

Por Hengeveld, P J, Kersten, M J
Publicado no Blood Cancer J (2015)

Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma.

Por Kersten, M J, Klein, M R, Holwerda, A M, Miedema, F, van Oers, M H
Publicado em 1997

Lessons learnt from a process evaluation of an exercise intervention in patients treated with autologous stem cell transplantation

Por Persoon, S., Chinapaw, M.J.M., Buffart, L.M., Brug, J., Kersten, M.J., Nollet, F.
Publicado no Eur J Cancer Care (Engl) (2017)

Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations

Por Kersten, M J, Kraan, W, Doorduijn, J, Bromberg, J, Lam, K, Kluin, P M, van der Holt, B J, Spaargaren, M, Pals, S T
Publicado no Blood Cancer J (2014)

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites

Por Kraan, W, Horlings, H M, van Keimpema, M, Schilder-Tol, E J M, Oud, M E C M, Scheepstra, C, Kluin, P M, Kersten, M J, Spaargaren, M, Pals, S T
Publicado em 2013

Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma

Por de Gast, G C, Batchelor, D, Kersten, M J, Vyth-Dreese, F A, Sein, J, van de Kasteele, W F, Nooijen, W J, Nieweg, O E, Waal, M A de, Boogerd, W
Publicado em 2003

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-α in patients with progressive metastatic renal cell carcinoma

Por Verra, N, Jansen, R, Groenewegen, G, Mallo, H, Kersten, M J, Bex, A, Vyth-Dreese, F A, Sein, J, van de Kasteele, W, Nooijen, W J, de Waal, M, Horenblas, S, de Gast, G C
Publicado em 2003

Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens

Por Oosten, L. E. M., Chamuleau, M. E. D., Thielen, F. W., de Wreede, L. C., Siemes, C., Doorduijn, J. K., Smeekes, O. S., Kersten, M. J., Hardi, L., Baars, J. W., Demandt, A. M. P., Stevens, W. B. C., Nijland, M., van Imhoff, G. W., Brouwer, R., Uyl-de Groot, C. A., Kluin, P. M., de Jong, D., Veelken, H.
Publicado no Ann Hematol (2017)